Search

everythinglearnresearchcommunity

for

Search:↓

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

PCOS treatment should address both symptoms and metabolic risks, starting with lifestyle changes and possibly including medication.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Higher leptin and lower vitamin D levels may contribute to male pattern baldness.

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

Low PON1 levels may indicate and predict the severity of hair loss.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Women with PCOS have a higher chance of experiencing depression, anxiety, and sleep disorders.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

Finding new uses for existing drugs is promising and can lead to safer, more effective medicines.

Vitamin E helps reduce PCOS symptoms and improves hormonal balance.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Women with PCOS may have higher bad cholesterol and are at risk for blood sugar issues; lifestyle changes are recommended.

Syphilis is becoming more common and remains a major health problem due to challenges in prevention and treatment.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

New LPA receptors (LPA4, LPA5, LPA6) have diverse roles in the body.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

Camellia japonica extract may improve scalp health and promote hair growth.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Low IGF-1 and high HDL cholesterol levels are linked to more hair loss in middle-aged women.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.